MI risks of diabetes drug

Rosiglitazone (Avandia) could increase the risk of MI by 43 per cent in patients with type-2 diabetes, US scientists claim.

The findings come from a meta-analysis of 42 trials, involving almost 18,000 patients aged an average of 56 years.

It also showed that the risk of death from all cardiovascular causes was 63 per cent higher in patients given rosiglitazone, compared with those given drug regimens excluding rosiglitazone.

Until more precise estimates of the risks of this treatment on cardiovascular health were carried out, providers should give 'careful consideration to the risks and benefits of their overall treatment plans', according to the researchers from the Cleveland Clinic in Ohio.

A spokeswoman for the MHRA said product information for rosiglitazone always had warnings on this risk and was updated by the European Medicines Agency in 2006. She added the safety of Avandia was being kept under review.

What do you think? Comment below or email us at GPletters@haymarket.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

BMA demands emergency meeting with government over GP abuse

BMA demands emergency meeting with government over GP abuse

BMA leaders have requested an emergency summit with the government to discuss ‘unacceptable...

Millions of pounds lost to general practice as flagship recruitment scheme falls short

Millions of pounds lost to general practice as flagship recruitment scheme falls short

Tens of millions of pounds in funding from a flagship recruitment scheme set up to...

Man charged with assault after attack on Manchester GP surgery staff

Man charged with assault after attack on Manchester GP surgery staff

A man has been charged with assault after four members of staff at a GP surgery in...

General practice in Cornwall 'on the brink of crisis', says LMC

General practice in Cornwall 'on the brink of crisis', says LMC

General practice in Cornwall is 'on the brink of a crisis' and may not cope this...

Flu vaccine deliveries to start from this week, supplier confirms

Flu vaccine deliveries to start from this week, supplier confirms

GP practices will begin to receive delayed flu vaccine supplies this week after supplier...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...